Skip to content

Effectivity of different oxygen therapy devices in patients with chronic lung disease in the inflight environment: oxygen cylinders vs. oxygen concentrators

Effectivity of different oxygen therapy devices in patients with chronic lung disease in the inflight environment: oxygen cylinders vs. oxygen concentrators

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004257
Enrollment
11
Registered
2012-07-20
Start date
2011-07-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.9

Interventions

Group 1: Patients mit COPD II/III according to GOLD are exposed in a random manner to six different oxygen delivering devices for 30 min: Arm 1: Freestyle (Airsep) During the study, exercise was not

Sponsors

Medizinische Klinik Innenstadt, Pneumologie, Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: COPD Grade II / III according GOLD guidelines stable phase of disease living in Munich subjective feeling that weather does influence the disease

Exclusion criteria

Exclusion criteria: - concurrent severe disease (as dementia, carcinoma, right heart failure, stroke, myocardial infarction) - continuous oxygen therapy - high altitude fear - reduced PaO2 50 mmHg - patients with emphysema (intrathoracic gas volume larger 130 % predicted)

Design outcomes

Primary

MeasureTime frame
Main study objective was the arterial oxygenation after 30 min of exposure with each of the tested devices or after room air at 2650 m. Oxygenation was evaluated by blood gases from the arterialised ear lobe (PaO2, partial oxygen pressure).

Secondary

MeasureTime frame
Oxygen saturation (SaO2) was measured by pulse oxymetrie after 30 min of exposure with one of the tested devices or with room air at 2650 m. Carbon dioxide partial pressure (PaCO2) was assessed together with the primary outcome (PaO2) by arterial blood gas measurement.

Countries

Germany

Contacts

Public ContactRainald Fischer

Medizinische Klinik Innenstadt, Pneumologie, Universität München

rfischer@med.uni-muenchen.de0049 89 5160 2111

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026